Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
JDRF is committed to ensuring that the needs of people with type 1 diabetes are taken into account and prioritised in the event of a no deal Brexit and is working closely with the Department of Health and Social Care on the situation for insulin supplies.
The UK government advises that patients, GPs, hospitals and pharmacies should not stockpile. Instead it has requested that drug manufacturers have a minimum of six weeks’ supply of stockpiled insulin, over and above their usual operational buffer stocks.
Insulin manufacturers, Novo Nordisk and Sanofi previously stated they were increasing their stockpiles to 16 and 14 weeks respectively, while Lilly is holding several months’ supply.
https://jdrf.org.uk/news/jdrf-updat...he-event-of-a-no-deal-brexit-january-17-2019/
The UK government advises that patients, GPs, hospitals and pharmacies should not stockpile. Instead it has requested that drug manufacturers have a minimum of six weeks’ supply of stockpiled insulin, over and above their usual operational buffer stocks.
Insulin manufacturers, Novo Nordisk and Sanofi previously stated they were increasing their stockpiles to 16 and 14 weeks respectively, while Lilly is holding several months’ supply.
https://jdrf.org.uk/news/jdrf-updat...he-event-of-a-no-deal-brexit-january-17-2019/